Literature DB >> 26645478

Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.

Rossana de Aguiar Cordeiro1,2,3, Antonio José de Jesus Evangelista1,2, Rosana Serpa1,3, Francisca Jakelyne de Farias Marques1,3, Charlline Vládia Silva de Melo1,3, Jonathas Sales de Oliveira1,3, Jônatas da Silva Franco1, Lucas Pereira de Alencar1,4, Tereza de Jesus Pinheiro Gomes Bandeira1,5, Raimunda Sâmia Nogueira Brilhante1,2,3, José Júlio Costa Sidrim1,2,3, Marcos Fébio Gadelha Rocha1,3,4.   

Abstract

Heat-shock proteins (Hsps) are chaperones required for the maintenance of cellular homeostasis in different fungal pathogens, playing an important role in the infectious process. This study investigated the effect of pharmacological inhibition of Hsp90 by radicicol on the Cryptococcus neoformans/Cryptococcus gattii species complex--agents of the most common life-threatening fungal infection amongst immunocompromised patients. The influence of Hsp90 inhibition was investigated regarding in vitro susceptibility to antifungal agents of planktonic and sessile cells, ergosterol concentration, cell membrane integrity, growth at 37 °C, production of virulence factors in vitro, and experimental infection in Caenorhabditis elegans. Hsp90 inhibition inhibited the in vitro growth of planktonic cells of Cryptococcus spp. at concentrations ranging from 0.5 to 2 μg ml(-1) and increased the in vitro inhibitory effect of azoles, especially fluconazole (FLC) (P < 0.05). Inhibition of Hsp90 also increased the antifungal activity of azoles against biofilm formation and mature biofilms of Cryptococcus spp., notably for Cryptococcus gattii. Furthermore, Hsp90 inhibition compromised the permeability of the cell membrane, and reduced planktonic growth at 37 °C and the capsular size of Cryptococcus spp. In addition, Hsp90 inhibition enhanced the antifungal activity of FLC during experimental infection using Caenorhabditis elegans. Therefore, our results indicate that Hsp90 inhibition can be an important strategy in the development of new antifungal drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26645478     DOI: 10.1099/mic.0.000222

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  21 in total

Review 1.  Combinatorial strategies for combating invasive fungal infections.

Authors:  Michaela Spitzer; Nicole Robbins; Gerard D Wright
Journal:  Virulence       Date:  2016-06-07       Impact factor: 5.882

2.  Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors.

Authors:  David S Huang; Emmanuelle V LeBlanc; Tanvi Shekhar-Guturja; Nicole Robbins; Damian J Krysan; Juan Pizarro; Luke Whitesell; Leah E Cowen; Lauren E Brown
Journal:  J Med Chem       Date:  2019-09-26       Impact factor: 7.446

3.  Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence.

Authors:  Ci Fu; Sarah R Beattie; Andrew J Jezewski; Nicole Robbins; Luke Whitesell; Damian J Krysan; Leah E Cowen
Journal:  Genetics       Date:  2022-01-04       Impact factor: 4.402

4.  Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay.

Authors:  Lijian Xu; Yan Li; John B Biggins; Brian R Bowman; Gregory L Verdine; James B Gloer; J Andrew Alspaugh; Gerald F Bills
Journal:  Appl Microbiol Biotechnol       Date:  2018-02-02       Impact factor: 4.813

Review 5.  Structure-guided approaches to targeting stress responses in human fungal pathogens.

Authors:  Emmanuelle V LeBlanc; Elizabeth J Polvi; Amanda O Veri; Gilbert G Privé; Leah E Cowen
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

6.  Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity.

Authors:  Paul T Marcyk; Emmanuelle V LeBlanc; Douglas A Kuntz; Alice Xue; Francisco Ortiz; Richard Trilles; Stephen Bengtson; Tristan M G Kenney; David S Huang; Nicole Robbins; Noelle S Williams; Damian J Krysan; Gilbert G Privé; Luke Whitesell; Leah E Cowen; Lauren E Brown
Journal:  J Med Chem       Date:  2021-01-14       Impact factor: 7.446

Review 7.  Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

Authors:  Yunjin Lee; Emily Puumala; Nicole Robbins; Leah E Cowen
Journal:  Chem Rev       Date:  2020-05-22       Impact factor: 60.622

Review 8.  Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets.

Authors:  Ying Gong; Tao Li; Cuixiang Yu; Shujuan Sun
Journal:  Front Cell Infect Microbiol       Date:  2017-12-19       Impact factor: 5.293

9.  Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans.

Authors:  Sharanya Chatterjee; Utpal Tatu
Journal:  PLoS Negl Trop Dis       Date:  2017-08-04

Review 10.  Virulence Factors as Targets for Anticryptococcal Therapy.

Authors:  Renata V D M Azevedo; Juliana Rizzo; Marcio L Rodrigues
Journal:  J Fungi (Basel)       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.